Alpha RegistryClaim a profile
Published mark

Baxter International

BAXTER INTERNATIONAL INC

NYSE: BAX. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:70c70e42-499d-47b1-9ef6-53dab1fa7509
SEC CIK
0000010456
Website
www.baxter.com Open
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
Newest evidence
Mar 23, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Andrew HiderSince Feb 12, 2026
Chair
Brent Shafer
Independent
8 / 99 directors published
Published claims
424 distinct sources
Evidence records
100 pinned
Source conflicts
0None open

Built from 4 distinct sources and 10 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

CEO CHANGED

Andrew Hider executive of Baxter International, effective 2026-02-12.

EffectiveEffective Feb 12, 2026E4

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
President and Chief Executive OfficerAndrew HiderFeb 2026currentSource reportedE4
Executive Vice President and General CounselDavid S. RosenbloomFeb 2026currentSource reportedE5
Executive Vice President, Chief Financial OfficerJoel T. GradeFeb 2026currentSource reportedE6
Group President, Infusion Therapies Technologies & PharmaceuticalsMaria Cecilia SorianoFeb 2026currentSource reportedE7
Executive Vice President and Group President, Healthcare Systems TechnologiesReazur RasulFeb 2026currentSource reportedE8

Board of directors

Evidence

9 directors published. 8 of 9 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Amy A. WendellIndependent2019Compensation and Human CapitalCompensation and Human Capital; Quality and Regulatory ComplianceQuality and Regulatory ComplianceSource reportedE3
Andrew P. HiderNot independent2025None publishedSource reportedE3
Brent ShaferIndependentChair2022ESGNominating, Corporate Governance and Public PolicyNominating, Corporate Governance and Public Policy; ESG, chairSource reportedE3
David S. WilkesIndependent2021ESGNominating, Corporate Governance and Public PolicyNominating, Corporate Governance and Public Policy; Quality and Regulatory Compliance; ESGQuality and Regulatory ComplianceSource reportedE3
Jeffrey A. CraigIndependent2024None publishedSource reportedE3
Michael R. McDonnellIndependent2026AuditSource reportedE3
Nancy M. SchlichtingIndependent2021Compensation and Human Capital, chairCompensation and Human Capital · Chair; Quality and Regulatory ComplianceQuality and Regulatory ComplianceSource reportedE3
Patricia B. MorrisonIndependent2019AuditAudit; Nominating, Corporate Governance and Public Policy · Chair; ESG · ChairESG, chairNominating, Corporate Governance and Public Policy, chairSource reportedE3
William A. Ampofo IIIndependent2023Quality and Regulatory ComplianceSource reportedE3

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditNot publishedMichael R. McDonnell, Patricia B. MorrisonNot described in the published record
Audit; Nominating, Corporate Governance and Public Policy · Chair; ESG · ChairNot publishedPatricia B. MorrisonNot described in the published record
Compensation and Human CapitalNancy M. SchlichtingNancy M. Schlichting, Amy A. Wendellhuman_capital, financial
Compensation and Human Capital · Chair; Quality and Regulatory ComplianceNot publishedNancy M. Schlichtinghuman_capital, regulatory, financial
Compensation and Human Capital; Quality and Regulatory ComplianceNot publishedAmy A. Wendellhuman_capital, regulatory, financial
ESGPatricia B. MorrisonPatricia B. Morrison, Brent Shafer, David S. WilkesNot described in the published record
Nominating, Corporate Governance and Public PolicyPatricia B. MorrisonPatricia B. Morrison, Brent Shafer, David S. WilkesNot described in the published record
Nominating, Corporate Governance and Public Policy; ESGBrent ShaferBrent ShaferNot described in the published record
Nominating, Corporate Governance and Public Policy; Quality and Regulatory Compliance; ESGNot publishedDavid S. Wilkesregulatory
Quality and Regulatory ComplianceNot publishedAmy A. Wendell, David S. Wilkes, Nancy M. Schlichting, William A. Ampofo IIregulatory
Committee RecordAudit: Chair not stated; Members Michael R. McDonnell; Patricia B. Morrison
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_record:23
Committee AppointmentMichael R. McDonnell: member, Audit
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:24
Committee AppointmentPatricia B. Morrison: member, Audit
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:25
Committee RecordCompensation and Human Capital: Chair Nancy M. Schlichting; Members Nancy M. Schlichting (Chair); Amy A. Wendell
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_record:26
Committee AppointmentNancy M. Schlichting: chair, Compensation and Human Capital
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:27
Committee AppointmentAmy A. Wendell: member, Compensation and Human Capital
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:28
Committee RecordESG: Chair Patricia B. Morrison; Members Patricia B. Morrison (Chair); Brent Shafer; David S. Wilkes
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_record:29
Committee AppointmentPatricia B. Morrison: chair, ESG
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:30
Committee AppointmentBrent Shafer: member, ESG
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:31
Committee AppointmentDavid S. Wilkes: member, ESG
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:32
Committee RecordNominating, Corporate Governance and Public Policy: Chair Patricia B. Morrison; Members Patricia B. Morrison (Chair); Brent Shafer; David S. Wilkes
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_record:33
Committee AppointmentPatricia B. Morrison: chair, Nominating, Corporate Governance and Public Policy
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:34
Committee AppointmentBrent Shafer: member, Nominating, Corporate Governance and Public Policy
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:35
Committee AppointmentDavid S. Wilkes: member, Nominating, Corporate Governance and Public Policy
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:36
Committee RecordQuality and Regulatory Compliance: Chair not stated; Members Amy A. Wendell; David S. Wilkes; Nancy M. Schlichting; William A. Ampofo II
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_record:37
Committee AppointmentAmy A. Wendell: member, Quality and Regulatory Compliance
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:38
Committee AppointmentDavid S. Wilkes: member, Quality and Regulatory Compliance
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:39
Committee AppointmentNancy M. Schlichting: member, Quality and Regulatory Compliance
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:40
Committee AppointmentWilliam A. Ampofo II: member, Quality and Regulatory Compliance
Source reportedE9
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:committee_appointment:41

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerAndrew Hider, President and Chief Executive Officer, from Feb 12, 2026
Source reportedE4
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:leadership_role:18
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Index MembershipS&P 500 (SPX)
Source reportedE10
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:index_membership:42
Security ListingBAX (NYSE)
Source reportedE1
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:security_listing:43
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
IndexSecurityStatusEffectiveVerificationSource
S&P 500 (S&P Dow Jones Indices)NYSE: BAXcurrentSep 30, 1972inferredSlickcharts S&P 500 constituent table (public observation, not S&P DJI license)

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameBAXTER INTERNATIONAL INC
Source reportedE1
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:entity_status:3
Official Websitehttps://www.baxter.com
Source reportedE2
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:official_website:4
Published FactHealthcare
Source reportedE1
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:published_fact:7
Published Facthttps://www.baxter.com
Source reportedE2
company:70c70e42-499d-47b1-9ef6-53dab1fa7509:published_fact:8

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
10 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 6 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    BAXTER INTERNATIONAL INC Form 10-K (filed 2026-02-12)
    BAXTER INTERNATIONAL INC Form 10-K (filed 2026-02-12). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    BAXTER INTERNATIONAL INC DEF 14A 2026-03-23
    sec proxy. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    BAX 10-K executive officers
    sec filing. Published Feb 12, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    BAX 10-K executive officers
    sec filing. Published Feb 12, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    BAX 10-K executive officers
    sec filing. Published Feb 12, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    BAX 10-K executive officers
    sec filing. Published Feb 12, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    BAX 10-K executive officers
    sec filing. Published Feb 12, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    Audit
    board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 19 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    S&P 500
    Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
    Open web
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026
  • Andrew Hider executive of Baxter International, effective 2026-02-12.
  • David S. Rosenbloom executive of Baxter International, effective 2026-02-12.
  • Joel T. Grade executive of Baxter International, effective 2026-02-12.
  • Maria Cecilia Soriano executive of Baxter International, effective 2026-02-12.
  • Reazur Rasul executive of Baxter International, effective 2026-02-12.
  • Michael R. McDonnell seat on Baxter International, effective 2026-01-01.
  • Michael R. McDonnell member of Audit, effective 2026-01-01.
  • Andrew P. Hider seat on Baxter International, effective 2025-01-01.
  • Jeffrey A. Craig seat on Baxter International, effective 2024-01-01.
  • William A. Ampofo II seat on Baxter International, effective 2023-01-01.
  • Brent Shafer seat on Baxter International, effective 2022-01-01.
  • Brent Shafer chairs board Baxter International, effective 2022-01-01.
  • Nominating, Corporate Governance and Public Policy; ESG committee of Baxter International, effective 2022-01-01.
  • Brent Shafer chairs Nominating, Corporate Governance and Public Policy; ESG, effective 2022-01-01.
  • David S. Wilkes seat on Baxter International, effective 2021-01-01.
  • Nancy M. Schlichting seat on Baxter International, effective 2021-01-01.
  • Compensation and Human Capital · Chair; Quality and Regulatory Compliance committee of Baxter International, effective 2021-01-01.
  • Nancy M. Schlichting member of Compensation and Human Capital · Chair; Quality and Regulatory Compliance, effective 2021-01-01.
  • Nominating, Corporate Governance and Public Policy; Quality and Regulatory Compliance; ESG committee of Baxter International, effective 2021-01-01.
  • David S. Wilkes member of Nominating, Corporate Governance and Public Policy; Quality and Regulatory Compliance; ESG, effective 2021-01-01.
  • Amy A. Wendell seat on Baxter International, effective 2019-01-01.
  • Patricia B. Morrison seat on Baxter International, effective 2019-01-01.
  • Audit; Nominating, Corporate Governance and Public Policy · Chair; ESG · Chair committee of Baxter International, effective 2019-01-01.
  • Patricia B. Morrison member of Audit; Nominating, Corporate Governance and Public Policy · Chair; ESG · Chair, effective 2019-01-01.
  • Compensation and Human Capital; Quality and Regulatory Compliance committee of Baxter International, effective 2019-01-01.
  • Amy A. Wendell member of Compensation and Human Capital; Quality and Regulatory Compliance, effective 2019-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:70c70e42-499d-47b1-9ef6-53dab1fa7509, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/baxter-international-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership5
  4. Board9
  5. Committees10
  6. Control and voting0
  7. Authority to act4
  8. Financials2
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims7
  15. Coverage gaps16
  16. Linked people14
  17. Subject and corrections6
  18. Evidence10
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:70c70e42-499d-47b1-9ef6-53dab1fa7509
  • Cite this recordBaxter International
  • Copy canonical URLregistry.alpha.ac/companies/baxter-international-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Baxter InternationalCompany
  • Andrew HiderPerson
  • David S. RosenbloomPerson
  • Joel T. GradePerson
  • Maria Cecilia SorianoPerson
  • Reazur RasulPerson
  • Amy A. WendellPerson
  • Andrew P. HiderPerson
  • Brent ShaferPerson
  • David S. WilkesPerson
  • Jeffrey A. CraigPerson
  • Michael R. McDonnellPerson
  • Nancy M. SchlichtingPerson
  • Patricia B. MorrisonPerson
  • William A. Ampofo IIPerson
  • Sections
    OverviewBaxter International
  • MonitoringBaxter International
  • LeadershipBaxter International
  • BoardBaxter International
  • CommitteesBaxter International
  • Control and votingBaxter International
  • Authority to actBaxter International
  • FinancialsBaxter International
  • GovernanceBaxter International
  • RiskBaxter International
  • AI oversightBaxter International
  • LegalBaxter International
  • CompensationBaxter International
  • Other published claimsBaxter International
  • Coverage gapsBaxter International
  • Linked peopleBaxter International
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.